top of page
AdobeStock_499167239.jpeg
Laboratory_edited_edited_edited_edited_e

Fast, accurate and affordable graphene biosensors

ESAP

Open platform

The Digital Successor of Conventional Immunoassays for Screening

HemChip®

Specialized platform

Field-ready Microchips Capable of Complex, Simultaneous Detection

Product Applications

ESAP

Customer-defined antibody screening workflows

Biologics

istockphoto-1713235394-1024x1024_edited.jpg

Our graphene-based platform advances pharmaceutical development by shortening timelines for drugs and biologics. From initial discovery to validation, we enable reliable, high-throughput screening through low-cost development solutions.

Basic Research

pexels-edward-jenner-4031320.jpg

Our platform accelerates research by rapidly verifying antibody-antigen binding. By validating interactions before committing to labor-intensive assays like ELISA and Western Blot, we eliminate wasted effort on non-viable candidates. This pre-screening greatly preserves grant funding and lab time.

HemChip

®

Custom chips for portable multiplexed in-field detection

Biodefense

a-student-in-the-special-operations-combat-medic-course-60eaa0-1600.jpeg

Our cutting-edge platform transforms biodefense with rapid, reliable detection of biotoxins like ricin and botulinum. Our device delivers precise results for military operations.

Agriculture

tractor.png

The platform provides rapid on-field detection of multiple widely-used herbicides like dicamba and glyphosate in minutes. Our multiplexed biochip accurately tests for organic targets that remain challenging for lateral flow (LFIA) tests.

Drugs of Abuse

AdobeStock_219641726_edited.png

Our convenient and handheld detection system provides simple and reliable test for those monitored for drug use. When urine cup test does not provide a clear answer, our platform provides highly accurate, digitally displayed test results for a full panel of drugs of abuse. 

 Healthcare

Our graphene-based platform advances health diagnostics by delivering protein and small molecule results in five minutes. From emergency care to clinical trials, we enable faster, better patient decisions through affordable point-of-care solutions.

Multiplexing and custom assays made easy

Using graphene sensors and our patented bio preservation, Hememics has developed a low-cost, multiplexed biosensor platform for detecting small molecule, molecular and protein targets simultaneously

bottom of page